Community/Retail

Recreational drug use has been established as a risk factor for HIV acquisition, and many patients will find lifestyle modification—eschewing recreational drug use—difficult.

Diabesity is quickly transforming into a global health crisis that is no longer limited to developed countries.

Few health care innovations compare to vaccines in terms of reduced morbidity and mortality

Dispensing medication to patients can have many barriers. One of which can be language.

If you love a pharmacist, why not show them how much you care by getting them a creative, cool gift this Valentine’s Day?

The FDA recently accepted 2 new supplemental biologics license applications from Merck for pembrolizumab (Keytruda) in patients with bladder cancer.

Recently, pharmacy benefit managers (PBMs) have begun charging providers direct and indirect remuneration fees (DIR fees), which has resulted in many specialty pharmacies and physician-run practices closing their doors or increasing costs.

Bristol-Myers Squibb Company recently announced that the FDA approved nivolumab (Opdivo) injection for patients with advanced or metastatic urothelial carcinoma.

A Dallas pharmacist pleaded guilty last week for her involvement in a pill mill operation that partially ran out of her pharmacy.

Although previous reports have cited certain health benefits of cannabinoids, widespread legalization of the substance still faces scrutiny due to a lack of research.

A regular blogger bids farewell for now.

February 7 marks National Black HIV/AIDS Awareness Day, which promotes awareness of HIV and AIDS and the disparity in care between African Americans in the United States compared to individuals of different races.

The SpartanNash Foundation has invited store guests to join them in supporting local Habitat for Humanity affiliates in eight states.

Publix Super Markets is expanding its collaboration with Nemours Children’s Health System to provide retail pharmacy services at Nemours Children’s Specialty Care in Jacksonville, Florida.

The FDA has accepted AbbVie’s New Drug Application (NDA) for and granted priority review to its investigational, pan-genotype regimen of glecaprevir/pibrentasvir (G/P).

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A particularly dangerous synthetic substance – fentanyl – is increasingly making its way into illicit street drugs and causing drug overdose deaths to skyrocket.

Have scientists found a new drug that could curb alcohol cravings and treat addiction?

Free Radical Biology and Medicine has published a review of emerging aspects and future directions of vitamin E research in its November 2016 issue.

The FDA has approved Allergan’s supplemental new drug application to update the label for their complicated urinary tract infection (cUTI) treatment.

The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.

Adults who have HIV are more likely to develop diabetes than the general population, a study published in BMJ Open Diabetes Research & Care estimates.

Researchers at Kaiser Permanente suggest that triglyceride-lowering therapy in patients with type 2 diabetes can decrease medical costs in a new study published in the American Journal of Cardiology.

The Changing Landscape of Beta Blockers in Cirrhosis

Exponential technology, which refers to technology that is doubling in power and speed each year despite a continuous drop in price.

Officials from Sanofi Pasteur, the vaccine division of Sanofi, announced the availability of their new pediatric vaccine formulation in the United States.

ASHP has released a new edition of AHFS Drug Information (AHFS DI), the nation’s leading compendium of unbiased and authoritative drug information.

President Donald Trump signed an executive order this week that could have direct implications for the FDA.